In the context of Burkitt’s lymphoma, JUN remains a crucial protein for andrographolide, potentially serving as a marker protein for the therapeutic application of andrographolide in treating Burkitt’s lymphoma. This evidence concerns the gene JUN and Burkitt lymphoma.